Interventional Cardiology and Peripheral Vascular Devices Market by Product (Angioplasty Balloons, Angioplasty Stents, Angioplasty Catheters, Endovascular Aneurysm Repair Stent Grafts, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, and Accessories) - Global Opportunity Analysis and Industry Forecast, 2014-2022

October 2016 | 130 pages | ID: W7827F9735FEN
Allied Market Research

Abstracts

Interventional cardiology is a branch of cardiology that focuses on catheter-based technologies for the treatment of structural heart diseases. Catheterization is used to perform large number of procedures on heart. It involves the insertion of a sheath into the femoral artery or any large peripheral artery or vein, and cannulating the heart under X-ray visualization (commonly known as fluoroscopy). However, numerous interventional devices are used for treating peripheral vascular disorders that affect the circulatory system, resulting in plaque built-up in the arteries of arms and legs. Some of the interventional devices used in the market include balloons, catheters, guidewires, stents, and filters.
The world interventional cardiology & peripheral vascular devices market was $13,203 million in 2015 and is expected to reach $25,349 million by 2022 with a CAGR of 9.7%. Rise in prevalence of cardiovascular disorders, geriatric population, demand for minimally invasive procedures, and rapid technological advancements in these devices driven the market. According to the American Heart Association, approximately 5.5 million individuals are affected by heart failure in the U.S., and approximately 670,000 new cases of heart failure are diagnosed every year. According to the Heart & Stroke Foundation, Canada, approximately 66,000 Canadians succumbed to cardiac abnormalities and stroke in 2012. These estimates are expected to boost the demand for interventional cardiology & peripheral vascular devices in the coming years.
On the other hand, complications related to implantation of interventional cardiology & peripheral vascular devices, product recall & failure, and availability of effective conventional treatment options restrict the market growth. Conversely, development of bioabsorbable stents offers key opportunity to market players. Unfavorable reimbursement policies for interventional cardiology & peripheral vascular devices across various regions (mainly the developing countries) are major hindrances for the market growth.

The report segments the market based on product and geography. Based on product, the market is classified into angioplasty balloons, angioplasty stents, angioplasty catheters, endovascular aneurysm repair stent grafts, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and accessories. Angioplasty stents accounted for the major share of market in 2015; whereas plaque modification devices are the fastest growing segment during the forecast period. Plaque modification before a stent implant decreases the chance of restenosis. In addition, increase in prevalence of atherosclerosis and rise in obese population globally also fuel growth of these devices. Based on geography, the market is divided into North America, Europe, Asia-Pacific, and LAMEA regions North America accounted for the major share of the overall market in 2015, and Asia-Pacific is expected to be the fastest growing segment during the analysis period.
The market has witnessed several product launches and approvals in the recent years. For instance, in July 2016, Abbott Laboratories received FDA approval for Absorb bioresorbable heart stent. Absorb is a fully dissolvable stent for treatment of coronary artery diseases. This product launch not only enhanced the company’s vascular business, but also provided a better treatment option for blocked vessels of heart.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the market along with current trends and future estimations to elucidate the imminent investment pockets.
• The report provides a quantitative analysis for the period of 2014–2022 to enable stakeholders to capitalize on the prevailing market opportunities.
• Extensive analysis of the market based on product helps understand the type of devices used for treating blockages associated with chronic diseases.
• Competitive intelligence highlights the business practices followed by leading players across various regions.
• Comprehensive analysis of all geographic regions helps determine the prevailing opportunities in these regions.
• Key market players and their strategies are analyzed to understand the competitive outlook of the global market.
• Extensive analysis of the market is conducted by following key product positioning and monitoring the top contenders within the market framework.

KEY MARKET SEGMENTS

By Product

• Angioplasty Balloons
• Old/Normal Balloons
• Cutting and Scoring Balloons
• Drug-eluting Balloons
• Angioplasty Stents
• Drug-eluting Stents
• Bare Metal Stents
• Bioabsorbable Stents
• Angioplasty Catheters
• Angiography Catheters
• Guiding Catheters
• Endovascular Aneurysm Repair Stent Grafts
• Abdominal Aortic Aneurysm
• Thoracic Aortic Aneurysm
• Inferior Vena Cava (IVC) Filters
• Retrievable Filters
• Permanent Filters
• Plaque Modification Devices
• Thrombectomy Devices
• Atherectomy Devices
• Hemodynamic Flow Alteration Devices
• Embolic Protection Devices
• Chronic Total Occlusion Devices
• Accessories
• Vascular Closure Devices
• Introducer Sheaths
• Guidewires
• Balloon Inflation Devices

By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• Malaysia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Egypt
• Rest of LAMEA

KEY PLAYERS

• Abbott Laboratories
• B. Braun Melsungen AG
• Boston Scientific Corporation
• C. R. Bard, Inc.
• Cardinal Health, Inc.
• Cook Medical, Inc.
• Medtronic plc
• St. Jude Medical, Inc.
• Terumo Corporation
• The Spectranetics Corporation

Other players in the value chain include (profiles not included in the report)

• Edwards Lifesciences Corporation
• ABIOMED, Inc.
• AngioDynamics, Inc.
• Becton, Dickinson & Co.
• Lepu Medical Technology (Beijing) Co. Ltd.
• Baxter International Inc.
• Siemens AG
• 3M Company
• Biotronik SE & Co. KG
• Smith & Nephew plc
• Sahajananad Medical Technologies Ltd.
• HeartWare International, Inc.

Contents

CHAPTER 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Key players
1.5 Research methodology
  1.5.1 Secondary research
  1.5.2 Primary research
  1.5.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope
3.2 Key findings
  3.2.1 Top investment pockets
  3.2.2 Top winning strategies
    3.2.2.1 Competitive intelligence of companies and their strategies
3.3 Market share analysis, 2015
3.4 Market dynamics
  3.4.1 Drivers
    3.4.1.1 Growing geriatric population and increasing prevalence of chronic diseases
    3.4.1.2 Technological advancements
    3.4.1.3 Improving healthcare infrastructure in developing countries
    3.4.1.4 Development of minimally invasive procedures
    3.4.1.5 Increasing patient awareness
  3.4.2 Restraints
    3.4.2.1 High treatment cost
    3.4.2.2 Stringent approval process for interventional cardiology and peripheral vascular devices
  3.4.3 Opportunities
    3.4.3.1 Huge market opportunities in developing countries
    3.4.3.2 Development of Bioabsorbable stents
3.5 Clinical Trials

CHAPTER 4 WORLD INTERVENTIONAL CARDIOLGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT

4.1 Overview
  4.1.1 Market size and forecast
4.2 Angioplasty Balloons
  4.2.1 Old/Normal balloons
  4.2.2 Cutting and scoring balloons
  4.2.3 Drug eluting balloons
  4.2.4 Key market trends
  4.2.5 Key growth factors and opportunities
  4.2.6 Market size and forecast
4.3 Angioplasty Stents
  4.3.1 Coronary stents
    4.3.1.1 Bare-metal stents
    4.3.1.2 Drug-eluting stents (DES)
    4.3.1.3 Bioabsorbable stents
  4.3.2 Peripheral stents
  4.3.3 Key market trends
  4.3.4 Key growth factors and opportunities
  4.3.5 Market size and forecast
4.4 Angioplasty Catheters
  4.4.1 Angiography Catheters
  4.4.2 Guiding Catheters
  4.4.3 Key market trends
  4.4.4 Key growth factors and opportunities
  4.4.5 Market size and forecast
4.5 Endovascular Aneurysm Repair Stent Grafts
  4.5.1 Abdominal aortic aneurysm
  4.5.2 Thoracic aortic aneurysm
  4.5.3 Key market trends
  4.5.4 Key growth factors and opportunities
  4.5.5 Market size and forecast
4.6 Inferior Vena Cava (IVC) Filters
  4.6.1 Permanent filters
  4.6.2 Retrievable filters
  4.6.3 Key market trends
  4.6.4 Key growth factors and opportunities
  4.6.5 Market size and forecast
4.7 Plaque Modification Devices
  4.7.1 Thrombectomy devices
  4.7.2 Atherectomy devices
  4.7.3 Key market trends
  4.7.4 Key growth factors and opportunities
  4.7.5 Market size and forecast
4.8 Hemodynamic Flow Alteration Devices
  4.8.1 Embolic protection devices
  4.8.2 Chronic total occlusion devices
  4.8.3 Key market trends
  4.8.4 Key growth factors and opportunities
  4.8.5 Market size and forecast
4.9 Accessories
  4.9.1 Vascular closure devices
  4.9.2 Introducer sheaths
  4.9.3 Guidewires
  4.9.4 Balloon inflation devices
  4.9.5 Key market trends
  4.9.6 Key growth factors and opportunities
  4.9.7 Market size and forecast

CHAPTER 5 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022

5.1 Overview
  5.1.1 Market size and forecast
5.2 North America
  5.2.1 Key market trends
  5.2.2 Key growth factors and opportunities
  5.2.3 Market size and forecast
  5.2.4 U.S. market size and forecast
  5.2.5 Canada market size and forecast
  5.2.6 Mexico market size and forecast
5.3 Europe
  5.3.1 Key market trends
  5.3.2 Key growth factors and opportunities
  5.3.3 Market size and forecast
  5.3.4 Germany market size and forecast
  5.3.5 France market size and forecast
  5.3.6 U.K. market size and forecast
  5.3.7 Italy market size and forecast
  5.3.8 Spain market size and forecast
  5.3.9 Rest of Europe market size and forecast
5.4 Asia-Pacific
  5.4.1 Key market trends
  5.4.2 Key growth factors and opportunities
  5.4.3 Market size and forecast
  5.4.4 Japan market size and forecast
  5.4.5 China market size and forecast
  5.4.6 India market size and forecast
  5.4.7 Malaysia market size and forecast
  5.4.8 Australia market size and forecast
  5.4.9 Rest of Asia-Pacific market size and forecast
5.5 LAMEA
  5.5.1 Key market trends
  5.5.2 Key growth factors and opportunities
  5.5.3 Market size and forecast
  5.5.4 Brazil market size and forecast
  5.5.5 South Africa market size and forecast
  5.5.6 Egypt market size and forecast
  5.5.7 Rest of LAMEA market size and forecast

CHAPTER 6 COMPANY PROFILES

6.1 Abbott Laboratories
  6.1.1 Company Overview
  6.1.2 Company Snapshot
  6.1.3 Operating Business Segments
  6.1.4 Business Performance
  6.1.5 Key Strategic Moves & Developments
6.2 B. Braun Melsungen AG
  6.2.1 Company Overview
  6.2.2 Company Snapshot
  6.2.3 Operating Business Segments
  6.2.4 Business Performance
  6.2.5 Key Strategic Moves & Developments
6.3 Boston Scientific Corporation
  6.3.1 Company Overview
  6.3.2 Company Snapshot
  6.3.3 Operating Business Segments
  6.3.4 Business Performance
  6.3.5 Key Strategic Moves & Developments
6.4 C. R. Bard, Inc.
  6.4.1 Company Overview
  6.4.2 Company Snapshot
  6.4.3 Operating Business Segments
  6.4.4 Business Performance
  6.4.5 Key Strategic Moves & Developments
6.5 Cardinal Health, Inc.
  6.5.1 Company Overview
  6.5.2 Company Snapshot
  6.5.3 Operating Business Segments
  6.5.4 Business Performance
  6.5.5 Key Strategic Moves & Developments
6.6 Cook Medical, Inc.
  6.6.1 Company Overview
  6.6.2 Company Snapshot
  6.6.3 Operating Business Segments
  6.6.4 Key Strategic Moves & Developments
6.7 Medtronic plc
  6.7.1 Company Overview
  6.7.2 Company Snapshot
  6.7.3 Operating Business Segments
  6.7.4 Business Performance
  6.7.5 Key Strategic Moves & Developments
6.8 St. Jude Medical, Inc.
  6.8.1 Company Overview
  6.8.2 Company Snapshot
  6.8.3 Operating Business Segments
  6.8.4 Business Performance
  6.8.5 Key Strategic Moves & Developments
6.9 Terumo Corporation
  6.9.1 Company Overview
  6.9.2 Company Snapshot
  6.9.3 Operating Business Segments
  6.9.4 Business Performance
  6.9.5 Key Strategic Moves & Developments
6.10 The Spectranetics Corporation
  6.10.1 Company Overview
  6.10.2 Company Snapshot
  6.10.3 Operating Business Segments
  6.10.4 Business Performance
  6.10.5 Key Strategic Moves & Developments

List Of Tables

LIST OF TABLES

TABLE 1 WORLD INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 2 WORLD ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 3 ANGIOPLASTY BALLOONS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 4 WORLD ANGIOPLASTY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 5 WORLD CORONARY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 6 ANGIOPLASTY STENTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 7 WORLD ANGIOPLASTY CATHETERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 8 ANGIOPLASTY CATHETERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 9 WORLD ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 10 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 11 TYPES OF IVC FILTERS AVAILABLE IN THE MARKET
TABLE 12 WORLD INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 13 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 14 WORLD PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 15 PLAQUE MODIFICATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 16 WORLD HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 17 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 18 WORLD ACCESSORIES MARKET, BY TYPE, 2014-2022 ($MILLION)
TABLE 19 ACCESSORIES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 20 INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 21 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 22 NORTH AMERICA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 23 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24 EUROPE: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 25 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 26 ASIA-PACIFIC: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 27 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 28 LAMEA: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2014-2022 ($MILLION)
TABLE 29 ABBOTT: COMPANY SNAPSHOT
TABLE 30 ABBOTT: OPERATING SEGMENTS
TABLE 31 B. BRAUN: COMPANY SNAPSHOT
TABLE 32 B. BRAUN: OPERATING SEGMENTS
TABLE 33 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 34 BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 35 BARD: COMPANY SNAPSHOT
TABLE 36 BARD: OPERATING SEGMENTS
TABLE 37 CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 38 CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 39 COOK MEDICAL: COMPANY SNAPSHOT
TABLE 40 COOK MEDICAL: DIVISIONS
TABLE 41 MEDTRONIC: COMPANY SNAPSHOT
TABLE 42 MEDTRONIC: OPERATING SEGMENTS
TABLE 43 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 44 ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 45 TERUMO: COMPANY SNAPSHOT
TABLE 46 TERUMO: OPERATING SEGMENTS
TABLE 47 SPECTRANETICS: COMPANY SNAPSHOT
TABLE 48 SPECTRANETICS: OPERATING SEGMENTS

List Of Figures

LIST OF FIGURES

FIG. 1 WORLD INTERVENTIONAL CRDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, BY PRODUCT, 2015 VS 2022, ($MILLION)
FIG. 2 INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION
FIG. 3 TOP INVESTMENT POCKETS
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 6 TOP COMPANIES AND THEIR STRATEGIES
FIG. 7 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 8 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIG. 9 MARKET SHARE ANALYSIS, 2015
FIG. 10 TOP IMPACTING FACTORS: INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET
FIG. 11 CLINICAL TRIALS IN WORLD INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET
FIG. 12 CLINICAL TRIALS FOR INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES, (%)
FIG. 13 WORLD PERIPHERAL STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
FIG. 14 U.S. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 15 CANADA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 16 MEXICO INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 17 GERMANY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 18 FRANCE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 19 U.K. INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 20 ITALY INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 21 SPAIN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 22 REST OF EUROPE INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 23 JAPAN INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 24 CHINA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 25 INDIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 26 MALAYSIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 27 AUSTRALIA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 28 REST OF ASIA-PACIFIC INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 29 BRAZIL INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 30 SOUTH AFRICA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 31 EGYPT INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 32 REST OF LAMEA INTERVENTIONAL CARDIOLOGY & PERIPHERAL VASCULAR DEVICES MARKET, 2014-2022 ($MILLION)
FIG. 33 ABBOTT: NET SALES, 2013-2015 ($MILLION)
FIG. 34 ABBOTT: NET SALES, BY SEGMENT, 2015 (%)
FIG. 35 ABBOTT: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 36 ABBOTT: STRATEGY SHARE, (%)
FIG. 37 B. BRAUN: NET SALES, 2013-2015 ($MILLION)
FIG. 38 B. BRAUN: NET SALES, BY SEGMENT, 2015 (%)
FIG. 39 B. BRAUN: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 40 BOSTON SCIENTIFIC: NET SALES, 2013-2015 ($MILLION)
FIG. 41 BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2015 (%)
FIG. 42 BOSTON SCIENTIFIC: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 43 BOSTON SCIENTIFIC: STRATEGY SHARE, (%)
FIG. 44 BARD: NET SALES, 2013-2015 ($MILLION)
FIG. 45 BARD: NET SALES, BY SEGMENT, 2015 (%)
FIG. 46 BARD: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 47 CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
FIG. 48 CARDINAL HEALTH: NET SALES, BY SEGMENT, 2016 (%)
FIG. 49 CARDINAL HEALTH: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 50 MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIG. 51 MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIG. 52 MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 53 MEDTRONIC: STRATEGY SHARE, (%)
FIG. 54 ST. JUDE MEDICAL: NET SALES, 2013-2015 ($MILLION)
FIG. 55 ST. JUDE MEDICAL: NET SALES, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 56 ST. JUDE MEDICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 57 ST. JUDE MEDICAL: STRATEGY SHARE, (%)
FIG. 58 TERUMO: NET SALES, 2014-2016 ($MILLION)
FIG. 59 TERUMO: NET SALES, BY SEGMENT, 2016 (%)
FIG. 60 TERUMO: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 61 TERUMO: STRATEGY SHARE, (%)
FIG. 62 SPECTRANETICS: NET SALES, 2013-2015 ($MILLION)
FIG. 63 SPECTRANETICS: NET SALES, BY SEGMENT, 2015 (%)
FIG. 64 SPECTRANETICS: NET SALES, BY PRODUCT LINE, 2015 (%)
FIG. 65 SPECTRANETICS: STRATEGY SHARE, (%)